173 related articles for article (PubMed ID: 487957)
1. Treatment of infections due to nonsporing anaerobes.
Sprott MS; Ingham HR
Drugs; 1979 Aug; 18(2):137-49. PubMed ID: 487957
[No Abstract] [Full Text] [Related]
2. Changing trends in therapy of infections due to anaerobic bacteria.
Del Bene VE
J S C Med Assoc; 1976 Jul; 72(7):260-3. PubMed ID: 1067462
[No Abstract] [Full Text] [Related]
3. Aspects on antibacterial treatment of anaerobic infections.
Nordbring F; Nord CE
Scand J Infect Dis Suppl; 1982; 35():59-62. PubMed ID: 6762654
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic approaches to anaerobic infection.
Tally FP
Hosp Pract (Off Ed); 1981 Dec; 16(12):117-24, 129-32. PubMed ID: 6458550
[No Abstract] [Full Text] [Related]
5. Managing anaerobic infections.
Pegram S; Philp JR
Am Fam Physician; 1978 Mar; 17(3):186-95. PubMed ID: 564599
[No Abstract] [Full Text] [Related]
6. The need for and choice of chemotherapy for anaerobic infections.
Selkon JB
Scand J Infect Dis Suppl; 1981; 26():19-23. PubMed ID: 6941452
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial considerations in anaerobic infections.
Lerner PI
Med Clin North Am; 1974 May; 58(3):553-44. PubMed ID: 4822593
[No Abstract] [Full Text] [Related]
8. Spectrum and treatment of anaerobic infections.
Brook I
J Infect Chemother; 2016 Jan; 22(1):1-13. PubMed ID: 26620376
[TBL] [Abstract][Full Text] [Related]
9. Management of anaerobic infections.
Finegold SM; Bartlett JG; Chow AW; Flora DJ; Gorbach SL; Harder EJ; Tally FP
Ann Intern Med; 1975 Sep; 83(3):375-89. PubMed ID: 1190633
[TBL] [Abstract][Full Text] [Related]
10. [Sporeless anaerobic bacteria with special reference to resistance testing and resistance behavior].
Wolter M
Z Arztl Fortbild (Jena); 1983; 77(22):919-23. PubMed ID: 6362224
[No Abstract] [Full Text] [Related]
11. Anaerobic infection in cancer patients: comparative evaluation of clindamycin and cefoxitin.
Klastersky J; Coppens L; Mombelli G
Antimicrob Agents Chemother; 1979 Sep; 16(3):366-71. PubMed ID: 507792
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin and amoxicillin?
Weeda LW
J Tenn Dent Assoc; 2001; 81(1):34-6. PubMed ID: 11324196
[No Abstract] [Full Text] [Related]
13. Newer antimicrobial agents.
Neu HC
Postgrad Med; 1975 Sep; 58(3):55-60. PubMed ID: 1174266
[No Abstract] [Full Text] [Related]
14. Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections.
Gall SA; Kohan AP; Ayers OM; Hughes CE; Addison WA; Hill GB
Obstet Gynecol; 1981 Jan; 57(1):51-8. PubMed ID: 7005778
[TBL] [Abstract][Full Text] [Related]
15. Comparative clinical evaluation of mezlocillin and cefoxitin.
LeFrock JL; Molavi A; Carr B; Schell R; Smith B; Rolston K; Lentnek A
J Antimicrob Chemother; 1982 Jan; 9 Suppl A():199-203. PubMed ID: 6210667
[No Abstract] [Full Text] [Related]
16. [Postoperative pulmonary infections: role of antibiotic treatment].
Belcaro G; Cotellese R; Spigonaro F; Filippini A; Gargano E; Radocchia F
Chir Patol Sper; 1980 Aug; 28(4):233-44. PubMed ID: 7307695
[No Abstract] [Full Text] [Related]
17. Antimicrobial therapy of infections due to anaerobic bacteria.
Del Bene VE; Farrar WE
Semin Drug Treat; 1972; 2(3):295-312. PubMed ID: 4617925
[No Abstract] [Full Text] [Related]
18. Cefoxitin sodium therapy of anaerobic infections.
Busch DF; Heseltine PN; Meyer RD; Sutter VL; Finegold SM
J Antimicrob Chemother; 1978 Jul; 4(B):197-202. PubMed ID: 357386
[No Abstract] [Full Text] [Related]
19. A multicentre comparison of clindamycin and metronidazole in the treatment of anaerobic infections.
Collier J; Colhoun EM; Hill PL
Scand J Infect Dis Suppl; 1981; 26():96-100. PubMed ID: 6941465
[TBL] [Abstract][Full Text] [Related]
20. Use of clindamycin in lower respiratory tract infections.
Schreiner A
Scand J Infect Dis Suppl; 1984; 43():56-61. PubMed ID: 6598521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
